137 results on '"May BK"'
Search Results
2. Quantification of mRNA for the vitamin D metabolizing enzymes CYP27B1 and CYP24 and vitamin D receptor in kidney using real-time reverse transcriptase- polymerase chain reaction
- Author
-
Anderson, PH, primary, O'Loughlin, PD, additional, May, BK, additional, and Morris, HA, additional
- Published
- 2003
- Full Text
- View/download PDF
3. Tissue-specific distribution and regulation of CYP1
- Author
-
Hendrix, I, primary, Morris, HA, additional, and May, BK, additional
- Published
- 2000
- Full Text
- View/download PDF
4. Effects in vitro mineralisation on 1,25D and PTH induction of 25 hydroxyvitamin D-24-hydroxylase in UMR106 cells
- Author
-
Iida, S, primary, Turner, A, additional, Morris, HA, additional, and May, BK, additional
- Published
- 2000
- Full Text
- View/download PDF
5. Repression of basal transcription by vitamin D receptor: evidence for interaction of unliganded vitamin D receptor with two receptor interaction domains in RIP13delta1
- Author
-
Dwivedi, PP, primary, Muscat, GE, additional, Bailey, PJ, additional, Omdahl, JL, additional, and May, BK, additional
- Published
- 1998
- Full Text
- View/download PDF
6. Effect of Haemin on Endogenous Protein Synthesis in Oocytes of the Queensland Cane Toad Bufo marinus
- Author
-
Glenn, AR, primary and May, BK, additional
- Published
- 1975
- Full Text
- View/download PDF
7. Translation of Rabbit Haemoglobin mRNA in Oocytes of the Queensland Cane Toad, Bufo marinus
- Author
-
May, BK, primary and RGlenn, A, additional
- Published
- 1974
- Full Text
- View/download PDF
8. Vitamin D metabolism : new concepts and clinical implications
- Author
-
Anderson, PH, May, BK, and Morris, HA
- Abstract
The vitamin D endocrine system plays a primary role in the maintenance of calcium homeostasis as well as exerting a wider range of biological activities including the regulation of cellular differentiation and proliferation, immunity, and reproduction. Most of these latter activities have been demonstrated using in vitro techniques. A major issue is to place such in vitro findings into their physiological context. Vitamin D exerts its genomic effects through a nuclear gene transcription factor, the vitamin D receptor (VDR), while metabolism of vitamin D both to its biologically active form, as well as to its excretory product, plays a major role in determining biological activity at the tissue level. Considerable information has become available recently concerning the metabolism of vitamin D both in the kidney and in non-renal tissues. These data confirm the endocrine action of vitamin D through renal metabolism which provides 1,25 dihydroxyvitamin D (1,25D) to the circulation. The major organ responding to the endocrine action of 1,25D is the intestine where it controls absorption of calcium and phosphate. Preliminary information regarding the contribution of tissue-specific production of 1,25D to its paracrine/autocrine activity is now becoming available. In bone cells, these data provide evidence for the modulation of cell proliferation and stimulation of bone cell maturation. The relevance of these concepts to the clinical laboratory is discussed in the context of vitamin D insufficiency and the increased risk of hip fracture amongst the elderly.
- Published
- 2003
9. Prospects for Leveling the Playing Field for Black Children With Autism.
- Author
-
Constantino JN, Abbacchi AM, May BK, Klaiman C, Zhang Y, Lowe JK, Marrus N, Klin A, and Geschwind DH
- Subjects
- Humans, Child, United States epidemiology, Prevalence, Comorbidity, Autism Spectrum Disorder diagnosis, Autism Spectrum Disorder epidemiology, Autistic Disorder epidemiology, Intellectual Disability epidemiology
- Abstract
Among the many race-based health disparities that have persistently plagued the US population,
1 the disproportionate burden of adverse neurodevelopmental outcomes to Black children affected by autism spectrum disorder (ASD) is particularly devastating given its major lifelong consequences. Recently, in 3 successive reports from the Autism and Developmental Disabilities Monitoring (ADDM) program of the US Centers for Disease Control and Prevention (CDC) (birth cohort years 2014, 2016, and 2018), we and our collaborators reported that although the prevalence of community-diagnosed ASD had equalized for Black and non-Hispanic White (NHW) children in the United States, there has persisted a pronounced racial disparity in the proportion of ASD-affected children with comorbid intellectual disability (ID), on the order of 50% for Black children with ASD vs 20% for White children with ASD.2 Here, we provide data to support the following: much earlier diagnosis is possible; early diagnosis alone is not likely to close the ID comorbidity disparity; and judicious efforts over care as usual are necessary to ensure that Black children have access to timely implementation of developmental therapy, for which we observed promising associations with improved cognitive and adaptive outcomes in our sample., (Copyright © 2023 American Academy of Child and Adolescent Psychiatry. Published by Elsevier Inc. All rights reserved.)- Published
- 2023
- Full Text
- View/download PDF
10. Improving Beverage Choice in Adults with Developmental Disabilities: Implementation of a Token Reinforcement System in a Community Residential Setting.
- Author
-
May BK, Britwum K, and Nicol GE
- Subjects
- Adult, Beverages, Child, Developmental Disabilities therapy, Dietary Sucrose, Humans, Autism Spectrum Disorder, Token Economy
- Abstract
Individuals with developmental disabilities (DD) are twice as likely to have obesity than non-disabled individuals. Replacing the consumption of sugar sweetened beverages (SSBs) with water has many health benefits, including weight reduction. In this study, a token reinforcement system was implemented to increase water consumption and decrease the consumption of SSBs with 14 adult participants with DD living in a community-based independent supported living (ISL) center. Token reinforcement reduced the consumption of SSBs, with associated reductions in calorie consumption and body weight. Findings are especially important for treatment settings where resources for individualized meal planning and staffing to support comprehensive behavioral interventions may be limited., (© 2021. This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply.)
- Published
- 2022
- Full Text
- View/download PDF
11. On the Importance of Listening and Intercultural Communication for Actions against Racism.
- Author
-
Baires NA, Catrone R, and May BK
- Abstract
In a period where racial inequities in the United States have garnered more attention and discussion as a result of social media (e.g., increased use of the #BlackLivesMatter hashtag; Anderson et al., 2020) and newer generations (Tatum, 2017b), it is important to ensure that communication between cultural groups is effective and produces systemic change. This article will review the failures of a "postracial" society, with emphasis on ineffective communication among Black, Indigenous People of Color and non-Black, Indigenous People of Color. The role of the listener during intercultural verbal exchanges will be examined, while highlighting the barriers and harmful results of ineffective communication. A behavioral conceptualization of effective listener behavior will be presented, which if implemented, may maintain and sustain social equity, inclusion, and justice. A call to action will be made to further investigate intercultural communication using behavior-analytic research methodologies and how such research might inform on how to functionally and precisely mediate reinforcement in the fight against racism., Competing Interests: Conflict of InterestThe authors declare that they have no conflict of interest., (© Association for Behavior Analysis International 2021.)
- Published
- 2021
- Full Text
- View/download PDF
12. Discovery and characterisation of circular bacteriocin plantacyclin B21AG from Lactiplantibacillus plantarum B21.
- Author
-
Golneshin A, Gor MC, Williamson N, Vezina B, Van TTH, May BK, and Smith AT
- Abstract
Lactiplantibacillus plantarum B21 isolated from Vietnamese sausage ( nem chua ) has previously displayed broad antimicrobial activity against Gram-positive bacteria including foodborne pathogens Listeria monocytogenes and Clostridium perfringens . This study successfully identified the antimicrobial agent as plantacyclin B21AG, a 5668 Da circular bacteriocin demonstrating high thermostability, resistance to a wide range of pH, proteolytic resistance and temporal stability. We report a reverse genetics approach to identify and characterise plantacyclin B21AG from first principles. The bacteriocin was purified from culture supernatant by a three-step process consisting of concentration, n-butanol extraction and cation exchange chromatography. A de novo peptide sequencing using LC-MS/MS techniques identified two putative peptide fragments which were mapped to the genome sequence of L. plantarum B21. This revealed an ORF corresponding to a putative circular bacteriocin with a 33-amino acid leader peptide and a 58-amino acid mature peptide encoded on a native plasmid pB21AG01. The bacteriocin is shown to be a small cationic predominantly α-helical protein (69%). The corresponding gene cluster, consisted of seven genes associated with post-translational circularisation, immunity and secretion. Whilst plantacyclin B21AG is 86% identical to the newly published plantaricyclin A it is more highly cationic having a net charge of +3 due to an additional basic residue in the putative membrane interaction region. This and other substitutions may well go some way to explaining functional differences. The robust nature of plantacyclin B21AG, its antimicrobial activity and associated machinery for cyclisation make it an interesting biotechnological target for development, both as a food-safe antimicrobial or potentially a platform technology for recombinant protein circularisation., (© 2020 The Author(s).)
- Published
- 2020
- Full Text
- View/download PDF
13. Increasing Exercise Intensity: Teaching High-Intensity Interval Training to Individuals with Developmental Disabilities Using a Lottery Reinforcement System.
- Author
-
May BK and Treadwell RE
- Abstract
Rates of overweight and obesity are above 70% in typically developing adults in the United States, with higher rates observed in individuals diagnosed with developmental disability (DD). Lottery reinforcement systems have been validated as effective exercise interventions for individuals with DD. Although high-intensity interval training (HIIT) has demonstrated health benefits, it has not been studied using individuals within this population. The purpose of this study was to implement a lottery reinforcement system to systematically increase heart rate (HR) during 30-min HIIT sessions with 3 adults with DD. Results demonstrated increases in HR from below to within the prescribed range in all 3 participants. For 1 participant, weight decreased by 10.8 pounds during the 9-week program. Implications include that lottery systems increase exercise intensity with adults with DD, that HR during exercise can be reliably controlled using a lottery system, and that similar programs may result in health benefits., Competing Interests: Conflict of InterestAll authors declare no conflicts of interest., (© Association for Behavior Analysis International 2020.)
- Published
- 2020
- Full Text
- View/download PDF
14. Metabolic Insights Into the Effects of Nutrient Stress on Lactobacillus plantarum B21.
- Author
-
Parlindungan E, May BK, and Jones OAH
- Abstract
Lactobacillus plantarum B21 is a strain of lactic acid bacteria first isolated from a fermented meat product from Vietnam. It is also a promising biopreservative with potential use in the food industry as it is a source of a novel bacteriocin (Plantacyclin B21AG) which has inhibitory effects against a wide range of species, including several pathogenic and spoilage strains. Nutrient stress is known to increase the survivability, storage stability, and bacteriocin production capability of L. plantarum B21 during industrial processing. It is however, unknown what the underlying biochemical responses that control these abilities are. This study therefore investigates the metabolite profiles of L. plantarum B21 using NMR spectroscopy and GC-MS to further understand the biochemical responses of this strain to various stress events. Unstressed cells were found to use glucose as their primary energy source with high concentrations of metabolites involved in glycolysis and organic acid synthesis, such as lactic acid, acetic acid, propanoic acid, malic acid, and 2-butenedioic acid being present in these cells. In contrast, large numbers of metabolites involved in amino acid metabolism including alanine, glutamic acid, aspartic acid, valine, proline, and norleucine were upregulated in glucose stressed cells, indicating that they were using amino acids as their main source of energy. Differences in levels of fatty acids, particularly octadecenoic acid, tetracosanoic acid, and 7-hexadecenoic acid were also observed between stressed and unstressed cells. The results from this study provide insight on the biochemical response of this bacterial strain to stresses commonly found during industrial processing.
- Published
- 2019
- Full Text
- View/download PDF
15. PEAK Pre-Assessments: Preliminary Evidence Establishing Internal Consistency and Construct Validity.
- Author
-
May BK and Flake L
- Abstract
Promoting the Emergence of Advanced Knowledge (PEAK) is a behavior-analytic tool that assesses and teaches language and cognitive abilities. PEAK preassessment total scores showed statistically significant correlations with measures of intelligence ( r = .703, p = .023) and adaptive behavior ( r = .618, p = .018), whereas no significant correlations were found between PEAK and age, autism diagnostic instruments, or aggression scales in a sample ( N = 18) receiving behavior-analytic assessment in an autism clinic. Statistically significant correlations were found between all modules within the PEAK system ( p ≤ .001). Results provide preliminary evidence of the construct validity and internal consistency of the PEAK preassessments., Competing Interests: Conflict of InterestAll authors declare they have no conflicts of interest., (© Association for Behavior Analysis International 2019.)
- Published
- 2019
- Full Text
- View/download PDF
16. On spray drying of oxidized corn starch cross-linked gelatin microcapsules for drug release.
- Author
-
Dang X, Yang M, Shan Z, Mansouri S, May BK, Chen X, Chen H, and Woo MW
- Subjects
- Ascorbic Acid metabolism, Drug Liberation, Hydrogen-Ion Concentration, Microscopy, Electron, Scanning, Osmolar Concentration, Oxidation-Reduction, Thermogravimetry, Ascorbic Acid chemistry, Capsules chemistry, Drug Carriers chemistry, Gelatin chemistry, Starch chemistry, Zea mays metabolism
- Abstract
Spray-dried gelatin/oxidized corn starch (G/OCS) microcapsules were produced for drug release application. The prepared microcapsules were characterized through a scanning electron microscope (SEM) picture and thermogravimetric analysis (TGA). The swelling characteristics of the G/OCS microcapsules and release properties of vitamin C were then investigated. The results from structural analysis indicated that the presence of miscibility and compatibility between oxidized corn starch and gelatin, and exhibits high thermal stability up to 326°C. The swelling of G/OCS microcapsules increased with increasing pH and reduced with decreasing ionic strength, attributed to the cross-linking between gelatin and oxidized corn starch, ionization of functional groups. Vitamin C release characteristic revealed controlled release behavior in the first 3h of contact with an aqueous medium. This release behavior was independent of the swelling behavior indicating the potential of the encapsulating matrix to produce controlled release across a spectrum of pH environment., (Copyright © 2016 Elsevier B.V. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF
17. The behaviour of whey protein isolate in protecting Lactobacillus plantarum.
- Author
-
Khem S, Small DM, and May BK
- Subjects
- Hydrophobic and Hydrophilic Interactions, Lactobacillus plantarum chemistry, Whey Proteins chemistry
- Abstract
There is increasing evidence that whey protein isolates (WPI), can be utilised to encapsulate and protect bioactive substances, including lactic acid bacteria, due to their physicochemical properties. However, little is known about what happens in the immediate vicinity of the cells. This study examined the protective behaviour of WPI for two strains of Lactobacillus plantarum, A17 and B21, during spray drying. B21 was found to be more hydrophobic than A17 and required 50% of the amount of WPI to provide comparably high survival (∼ 90%). We hypothesise that WPI protects the hydrophobic bacteria by initial attachment to the unfolded whey protein due to hydrophobic interactions followed by adhesion to the proteins, resulting in cells being embedded within the walls of the capsules. The encapsulated strains had a moisture content of approximately 5.5% and during storage trials at 20 °C retained viability for at least eight weeks., (Copyright © 2015 Elsevier Ltd. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
18. Complete Genome Sequence of Lactobacillus plantarum Strain B21, a Bacteriocin-Producing Strain Isolated from Vietnamese Fermented Sausage Nem Chua.
- Author
-
Golneshin A, Adetutu E, Ball AS, May BK, Van TT, and Smith AT
- Abstract
Lactobacillus plantarum strain B21 was isolated from Vietnamese sausage (nem chua) and demonstrated broad antimicrobial activity due to the production of bacteriocins. Here, we report the complete genome sequence of this strain (3,284,260 bp)., (Copyright © 2015 Golneshin et al.)
- Published
- 2015
- Full Text
- View/download PDF
19. Agent selection and protective effects during single droplet drying of bacteria.
- Author
-
Khem S, Woo MW, Small DM, Chen XD, and May BK
- Subjects
- Lactobacillus plantarum chemistry, Lactose chemistry, Trehalose chemistry
- Abstract
The protective mechanisms of whey protein isolate (WPI), trehalose, lactose, and skim milk on Lactobacillus plantarum A17 during convective droplet drying has been explored. A single droplet drying technique was used to monitor cell survival, droplet temperature and corresponding changes in mass. WPI and skim milk provided the highest protection amongst the materials tested. In situ analysis of the intermediate stage of drying revealed that for WPI and skim milk, crust formation reduces the rate of sudden temperature increase thereby imparting less stress on the cells. Irreversible denaturation of the WPI components might have also contributed to the protection of the cells. Skim milk, however, 'loses' the protective behaviour towards the latter stages of drying. This indicates that the concentration of the WPI components could be another possible factor determining the sustained protective behaviour during the later stages of drying when the moisture content is low., (Copyright © 2014 Elsevier Ltd. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
20. Systematic characterisation of the rat and human CYP24A1 promoter.
- Author
-
Kumar R, Iachini DN, Neilsen PM, Kaplan J, Michalakas J, Anderson PH, May BK, Morris HA, and Callen DF
- Subjects
- Animals, Base Sequence, Binding Sites, Cells, Cultured, Cholecalciferol pharmacology, Genes, Reporter drug effects, Humans, Rats, Receptors, Calcitriol metabolism, Sequence Homology, Nucleic Acid, Steroid Hydroxylases analysis, Steroid Hydroxylases metabolism, Transfection, Vitamin D Response Element physiology, Vitamin D3 24-Hydroxylase, Promoter Regions, Genetic physiology, Steroid Hydroxylases genetics
- Abstract
The biologically active form of vitamin D, 1,25-dihydroxyvitamin D (1,25D) ligands VDR (vitamin D receptor) and binds to the vitamin D response element (VDRE) located within target genes to regulate their transcription. Previously we showed that 1,25D-mediated rat CYP24A1 induction via the two critical VDREs is dependent on a short stretch of nucleotides called vitamin D stimulating element (VSE), located approximately 30bp upstream of VDRE-1 in the rat CYP24A1 promoter. We have now undertaken systematic analysis of the human CYP24A1 and rat CYP24A1 promoters to determine if the VSE is present in the human promoter. Using electrophoretic mobility shift and dual-luciferase reporter assays, we show that the VSE is absent in the human CYP24A1 promoter. In addition, we show that 1,25D-mediated induction of human CYP24A1 is dependant upon a promoter region spanning nucleotides -470 to -392 of the human CYP24A1 promoter., (Crown Copyright (c) 2010. Published by Elsevier Ireland Ltd. All rights reserved.)
- Published
- 2010
- Full Text
- View/download PDF
21. A role for the phosphatidylinositol 3-kinase--protein kinase C zeta--Sp1 pathway in the 1,25-dihydroxyvitamin D3 induction of the 25-hydroxyvitamin D3 24-hydroxylase gene in human kidney cells.
- Author
-
Dwivedi PP, Gao XH, Tan JC, Evdokiou A, Ferrante A, Morris HA, May BK, and Hii CS
- Subjects
- Cell Line, Chromones pharmacology, Humans, Kidney metabolism, Morpholines pharmacology, Mutation, Phosphatidylinositol 3-Kinases metabolism, Phosphoinositide-3 Kinase Inhibitors, Phosphorylation, Promoter Regions, Genetic, Protein Kinase C metabolism, Sp1 Transcription Factor metabolism, Steroid Hydroxylases metabolism, Vitamin D3 24-Hydroxylase, Calcitriol pharmacology, Phosphatidylinositol 3-Kinases physiology, Protein Kinase C physiology, Sp1 Transcription Factor physiology, Steroid Hydroxylases genetics
- Abstract
The molecular mechanisms that underlie non-genomic induction of the 25-hydroxyvitamin D3 24-hydroxylase (CYP24) gene promoter by the steroid hormone, 1,25-Dihydroxyvitamin D3 (1,25D), are poorly understood. Although we have previously identified a functional inverted GC-box in the early promoter at -113/-105 bp, it is not known whether this site is important for 1,25D induction of the promoter. Using transfected human embryonic kidney (HEK) 293T cells, we now report the functional characterisation of the GC-box and that 1,25D induction of the promoter requires PI3-kinase, PKCzeta and Sp1 but not Sp3. The data show that 1,25D rapidly stimulates PI3-kinase activity which is required for the activation of PKCzeta and the phosphorylation of Sp1. The effects of the PI3-kinase inhibitor, LY294002, and a dominant negative PKCzeta mutant on 1,25D induction of wild-type and a GC-box mutated CYP24 promoter constructs are consistent with the Sp1 site being the target of both kinases. However, these kinases are not required for basal expression of the CYP24 promoter. The data establish a novel non-genomic mechanism which couples 1,25D to the induction of CYP24 gene transcription via the PI3-kinase--PKCzeta--Sp1 pathway acting through the GC-box.
- Published
- 2010
- Full Text
- View/download PDF
22. Regulation of the 5'-flanking region of the human CYP27B1 gene in osteoblast cells.
- Author
-
Turner AG, Dwivedi PP, Anderson PH, May BK, and Morris HA
- Subjects
- Animals, Base Sequence, Cell Line, Tumor, DNA Mutational Analysis, Enhancer Elements, Genetic genetics, Humans, Molecular Sequence Data, Osteoblasts drug effects, Promoter Regions, Genetic genetics, Rats, Sequence Deletion, Transforming Growth Factor beta pharmacology, 25-Hydroxyvitamin D3 1-alpha-Hydroxylase genetics, 5' Flanking Region genetics, Gene Expression Regulation drug effects, Osteoblasts enzymology
- Abstract
Synthesis of 1,25-dihydroxyvitamin D(3) (1,25(OH)(2)D(3)) is catalysed by the enzyme 25-hydroxyvitamin D(3)-1alpha-hydroxylase (CYP27B1). Regulation of CYP27B1 gene expression is poorly understood, particularly in non-renal tissues including bone where 1,25(OH)(2)D(3) is hypothesised to serve autocrine/paracrine roles. Transient transfection of ROS 17/2.8 osteoblast-like cells with reporter gene constructs containing deletions of the 5'-flanking region of the human CYP27B1 gene revealed a proximal promoter, enhancer region and strong upstream repressive region. Putative CCAAT and GC boxes, as well as Ets protein binding sites were shown to contribute to promoter and enhancer activities respectively in common with kidney and prostate cells. Inhibition of basal expression was largely attributed to a palindrome 5'-GTCTCAGAC-3' (-1015/-1007bp) that contains two putative canonical Smad binding elements. We conclude that repression of CYP27B1 gene expression may be a common event but the novel inhibitory elements we have identified may be unique to osteoblasts.
- Published
- 2009
- Full Text
- View/download PDF
23. Vitamin D depletion induces RANKL-mediated osteoclastogenesis and bone loss in a rodent model.
- Author
-
Anderson PH, Sawyer RK, Moore AJ, May BK, O'Loughlin PD, and Morris HA
- Subjects
- 25-Hydroxyvitamin D3 1-alpha-Hydroxylase genetics, 25-Hydroxyvitamin D3 1-alpha-Hydroxylase metabolism, Animals, Bone Resorption blood, Calcification, Physiologic, Disease Models, Animal, Femur anatomy & histology, Femur enzymology, Gene Expression Regulation, Enzymologic, Male, Organ Size, Osteomalacia blood, Osteomalacia complications, Osteomalacia physiopathology, Parathyroid Hormone blood, RNA, Messenger genetics, RNA, Messenger metabolism, Rats, Rats, Sprague-Dawley, Regression Analysis, Vitamin D analogs & derivatives, Vitamin D blood, Vitamin D Deficiency blood, Bone Resorption complications, Bone Resorption physiopathology, Osteogenesis, RANK Ligand metabolism, Vitamin D Deficiency complications, Vitamin D Deficiency physiopathology
- Abstract
The association between increased risk of hip fracture and low vitamin D status has long been recognized. However, the level of vitamin D required to maintain bone strength is controversial. We used a rodent model of vitamin D depletion to quantify the 25-hydroxyvitamin D (25D) levels required for normal mineralization. Six groups of 10-wk-old male Sprague-Dawley rats (n = 42) were fed a diet containing 0.4% calcium and various levels of dietary vitamin D(3) for 4 mo to achieve stable mean serum 25D levels ranging between 10 and 115 nM. At 7 mo of age, animals were killed, and the histomorphometry of distal and proximal femora and L(2) vertebra was analyzed. Total RNA was extracted from whole femora for real-time RT-PCR analyses. In the distal femoral metaphysis, trabecular bone mineral volume (BV/TV) showed a significant positive association with circulating 25D levels (r(2) = 0.42, p < 0.01) in the animals with serum 25D levels between 20 and 115 nM. Osteoclast surface (Oc.S) levels were positively associated with RANKL:OPG mRNA ratio, higher in groups with lower serum 25D levels, and were independent of serum 1,25D levels. Serum 25D levels <80 nM gave rise to osteopenia as a result of increased osteoclastogenesis, suggesting that levels of 25D >80 nM are needed for optimal bone volume. These data indicate that serum 25D levels are a major determinant of osteoclastogenesis and bone mineral volume and are consistent with the levels of 25D recommended to reduce the risk of fracture in humans.
- Published
- 2008
- Full Text
- View/download PDF
24. Co-expression of CYP27B1 enzyme with the 1.5kb CYP27B1 promoter-luciferase transgene in the mouse.
- Author
-
Anderson PH, Hendrix I, Sawyer RK, Zarrinkalam R, Manavis J, Sarvestani GT, May BK, and Morris HA
- Subjects
- 25-Hydroxyvitamin D3 1-alpha-Hydroxylase genetics, 5' Flanking Region, Animals, Humans, Male, Mice, Mice, Transgenic, Recombinant Fusion Proteins genetics, Tissue Distribution, 25-Hydroxyvitamin D3 1-alpha-Hydroxylase metabolism, Gene Expression Regulation, Enzymologic, Promoter Regions, Genetic, Recombinant Fusion Proteins metabolism, Transgenes
- Abstract
The renal enzyme 25-hydroxyvitamin D 1alpha-hydroxylase (CYP27B1), responsible for the synthesis of circulating. 1,25-dihydroxyvitamin D (1,25D), is also expressed in a number of non-renal tissues. The regulation of CYP27B1 expression by the short flanking promoter outside the kidney is, however, largely unknown. We have used a transgenic mice expressing the 1.5kb promoter of the human CYP27B1 gene fused to the firefly luciferase gene in order to investigate tissue-specific CYP27B1 expression. These transgenic animals demonstrated co-localised luciferase and endogenous CYP27B1 expression in kidney proximal convoluted tubular cells. Strong co-expression of luciferase and CYP27B1 also occurred in neurons and Purkinje cells of the cerebellum and in Leydig and Sertoli cells of the testes. Other tissues to exhibit CYP27B1-promoter directed luciferase activity included lung, prostate, trabecular bone and jejunum as well as the choroid epithelium. The tissue specific changes in luciferase activity were age-related. These findings demonstrate that the proximal 1.5kb 5' flanking region of the CYP27B1 gene directs the expression of CYP27B1 in a number of known and novel tissues in a specific manner.
- Published
- 2008
- Full Text
- View/download PDF
25. Antineoplastic agents target the 25-hydroxyvitamin D3 24-hydroxylase messenger RNA for degradation: implications in anticancer activity.
- Author
-
Tan J, Dwivedi PP, Anderson P, Nutchey BK, O'Loughlin P, Morris HA, May BK, Ferrante A, and Hii CS
- Subjects
- Animals, COS Cells, Cell Line, Tumor, Chlorocebus aethiops, Humans, Mitogen-Activated Protein Kinases metabolism, Promoter Regions, Genetic, RNA, Messenger metabolism, Up-Regulation, Vitamin D3 24-Hydroxylase, Antineoplastic Agents pharmacology, RNA, Messenger drug effects, Steroid Hydroxylases genetics
- Abstract
Calcitriol or 1,25-dihydroxyvitamin D(3) [1,25(OH)(2)D(3)] has antitumor activity and hence its levels in patients may play an important role in disease outcome. Here, we report that the antineoplastic agents, daunorubicin hydrochloride, etoposide, and vincristine sulfate inhibited the ability of 1,25(OH)(2)D(3) to cause the accumulation of mRNA for kidney 25-hydroxyvitamin D(3) 24-hydroxylase (CYP24), an enzyme which catabolizes this hormone. This was not due to a drug-induced cytotoxic effect, reduction in the expression of the vitamin D receptor or inhibition of the vitamin D receptor-mediated activation of the mitogen-activated protein kinases or CYP24 promoter activity. Interestingly, there was selective degradation of CYP24 mRNA in the presence of the drugs. This was accompanied by an enhancement in the levels of 1,25(OH)(2)D(3) in cells incubated with 25-hydroxy vitamin D(3). These data identify a novel mechanism of action of some commonly used antineoplastic agents which by decreasing the stability of CYP24 mRNA would prolong the bioavailability of 1,25(OH)(2)D(3) for anticancer actions.
- Published
- 2007
- Full Text
- View/download PDF
26. Role of oncoprotein growth factor independent-1 (GFI1) in repression of 25-hydroxyvitamin D 1alpha-hydroxylase (CYP27B1): a comparative analysis in human prostate cancer and kidney cells.
- Author
-
Dwivedi PP, Anderson PH, Tilley WD, May BK, and Morris HA
- Subjects
- 25-Hydroxyvitamin D3 1-alpha-Hydroxylase genetics, 5' Flanking Region, Binding Sites, Cell Line, Gene Expression Regulation, Humans, Male, Mutation genetics, Promoter Regions, Genetic genetics, Prostatic Neoplasms genetics, Response Elements, 25-Hydroxyvitamin D3 1-alpha-Hydroxylase metabolism, DNA-Binding Proteins metabolism, Kidney metabolism, Prostatic Neoplasms metabolism, Transcription Factors metabolism
- Abstract
1,25-Dihydroxyvitamin D (1,25D) inhibits growth of prostate cancer cells and has been proposed to play a protective role in prostate cancer. However, 25-hydroxyvitamin D 1alpha-hydroxylase (CYP27B1), the enzyme responsible for the cellular synthesis of 1,25D, is repressed in prostate cancer cells. Recently, we have identified a role for the transcription factor, Growth Factor Independent-1 (GFI1) in the repression of the CYP27B1 gene in human prostate cancer cell lines. GFI1 is known to form a large protein complex with co-repressors that recruit histone deacetylases. We have proposed a model for the molecular repression of CYP27B1 gene expression. The formation of such a repressive complex on the inhibitory domain of the CYP27B1 gene in prostate cancer cells could lead to the silencing of gene expression either by inactivating nearby enhancer or proximal promoter domains and lead to cancer progression by reducing local production of 1,25D. These studies demonstrate that GFI1 may play a significant role in the down regulation of endogenous production of 1,25D in prostate cancer cells and could provide a novel insight to future diagnosis and treatment.
- Published
- 2007
- Full Text
- View/download PDF
27. 25-Hydroxyvitamin D requirement for maintaining skeletal health utilising a Sprague-Dawley rat model.
- Author
-
Anderson PH, Sawyer RK, May BK, O'Loughlin PD, and Morris HA
- Subjects
- 25-Hydroxyvitamin D3 1-alpha-Hydroxylase genetics, Animals, Calcium blood, Kidney enzymology, Male, Models, Animal, Parathyroid Hormone blood, Phosphates blood, RNA, Messenger genetics, Rats, Rats, Sprague-Dawley, Steroid Hydroxylases genetics, Vitamin D blood, Vitamin D pharmacology, Vitamin D3 24-Hydroxylase, Bone and Bones metabolism, Health, Vitamin D analogs & derivatives
- Abstract
To study the role of vitamin D to optimise bone architecture, we have developed an animal model to investigate the effects of frank vitamin D-deficiency as well as graded depletion of circulating 25-hydroxyvitamin D(3) (25D) levels on the skeleton. Rats fed on dietary vitamin D levels from 0 to 500 ng/day achieved diet-dependent circulating levels of 25D ranging from 11 to 115 nmol/L. Levels of serum 1,25-dihydroxyvitamin D(3) (1,25D) increased as dietary vitamin D increased between 0 and 200 ng/day at which point a maximum level was achieved and retained with higher vitamin D intakes. The renal levels of 25-hydroxyvitamin D-1alpha-hydroxylase (CYP27B1) mRNA were highest in animal groups fed on vitamin D between 0 and 300 ng/day. In contrast, renal 25-hydroxyvitamin D 24-hydroxylase (CYP24) mRNA levels increased as dietary vitamin D increased achieving maximum levels in animals receiving 500 ng vitamin D/day. This animal model of vitamin D depletion is suitable to provide invaluable information on the serum levels of 25D and dietary calcium intake necessary for optimal bone structure. Such information is essential for developing nutritional recommendations to reduce the incidence of osteoporotic hip fractures.
- Published
- 2007
- Full Text
- View/download PDF
28. Regulation of the CYP27B1 5'-flanking region by transforming growth factor-beta in ROS 17/2.8 osteoblast-like cells.
- Author
-
Turner AG, Dwivedi PP, May BK, and Morris HA
- Subjects
- Animals, Cell Line, Tumor, Humans, Rats, 25-Hydroxyvitamin D3 1-alpha-Hydroxylase genetics, 25-Hydroxyvitamin D3 1-alpha-Hydroxylase metabolism, 5' Flanking Region genetics, Gene Expression Regulation, Enzymologic genetics, Osteoblasts drug effects, Osteoblasts enzymology, Transforming Growth Factor beta pharmacology
- Abstract
The biologically active form of vitamin D, 1,25-dihydroxyvitamin D(3) (1,25(OH)(2)D(3)), regulates osteoblast proliferation and differentiation. Production of 1,25(OH)(2)D(3) is catalysed by the enzyme 25-hydroxyvitamin D(3)-1alpha-hydroxylase (CYP27B1). Though highly expressed in the kidney, the CYP27B1 gene is also expressed in non-renal tissues including bone. It is hypothesised that local production of 1,25(OH)(2)D(3) by osteoblasts plays an autocrine or paracrine role. The aim of this study was to investigate what factors regulate expression of the CYP27B1 gene in osteoblast cells. ROS 17/2.8 osteoblast cells were transiently transfected with plasmid constructs containing the 5'-flanking sequence of the human CYP27B1 gene fused to a luciferase reporter gene. Cells were treated with either parathyroid hormone (PTH), 1,25(OH)(2)D(3), transforming growth factor-beta (TGF-beta) or insulin-like growth factor-1 (IGF-1) and luciferase activity was measured 24h later. The results showed that 1,25(OH)(2)D(3) did not alter expression of the reporter construct, however treatment with PTH, IGF-1 and TGF-beta decreased expression by 18, 53 and 58% respectively. The repressive action of TGF-beta was isolated to the region between -531 and -305bp. These data suggest that expression of the 5'-flanking region for the CYP27B1 gene in osteoblast cells may be regulated differently to that previously described in kidney cells.
- Published
- 2007
- Full Text
- View/download PDF
29. Haem repression of the housekeeping 5-aminolaevulinic acid synthase gene in the hepatoma cell line LMH.
- Author
-
Kolluri S, Sadlon TJ, May BK, and Bonkovsky HL
- Subjects
- Animals, Cell Line, Tumor, Chickens, Drug Synergism, Gene Expression Regulation, Neoplastic drug effects, Glutethimide pharmacology, Heme antagonists & inhibitors, Heme metabolism, Heptanoates pharmacology, Promoter Regions, Genetic genetics, Up-Regulation drug effects, 5-Aminolevulinate Synthetase genetics, Down-Regulation drug effects, Gene Expression Regulation, Enzymologic drug effects, Heme pharmacology
- Abstract
Haem is essential for the health and function of nearly all cells. 5-Aminolaevulinic acid synthase-1 (ALAS-1) catalyses the first and rate-controlling step of haem biosynthesis. ALAS-1 is repressed by haem and is induced strongly by lipophilic drugs that also induce CYP (cytochrome P450) proteins. We investigated the effects on the avian ALAS-1 gene promoter of a phenobarbital-like chemical, Glut (glutethimide), and a haem synthesis inhibitor, DHA (4,6-dioxoheptanoic acid), using a reporter gene assay in transiently transfected LMH (Leghorn male hepatoma) hepatoma cells. A 9.1 kb cALAS-1 (chicken ALAS-1) promoter-luciferase-reporter construct, was poorly induced by Glut and not by DHA alone, but was synergistically induced by the combination. In contrast, a 3.5 kb promoter ALAS-1 construct was induced by Glut alone, without any further effect of DHA. In addition, exogenous haem (20 microM) repressed the basal and Glut- and DHA-induced activity of luciferase reporter constructs containing 9.1 and 6.3 kb of ALAS-1 5'-flanking region but not the construct containing the first 3.5 kb of promoter sequence. This effect of haem was subsequently shown to be dependent on the -6.3 to -3.5 kb region of the 5'-flanking region of cALAS-1 and requires the native orientation of the region. Two deletion constructs of this approx. 2.8 kb haem-repressive region (1.7 and 1.1 kb constructs) retained haem-dependent repression of basal and drug inductions, suggesting that more than one cis-acting elements are responsible for this haem-dependent repression of ALAS-1. These results demonstrate that there are regulatory regions in the 5'-flanking region of the cALAS-1 gene that respond to haem and provide a basis for further investigations of the molecular mechanisms by which haem down-regulates expression of the ALAS-1 gene.
- Published
- 2005
- Full Text
- View/download PDF
30. Molecular action of 1,25-dihydroxyvitamin D3 and phorbol ester on the activation of the rat cytochrome P450C24 (CYP24) promoter: role of MAP kinase activities and identification of an important transcription factor binding site.
- Author
-
Nutchey BK, Kaplan JS, Dwivedi PP, Omdahl JL, Ferrante A, May BK, and Hii CS
- Subjects
- Animals, Binding Sites, Cell Line, Enzyme Activation, Enzyme Induction, Humans, JNK Mitogen-Activated Protein Kinases metabolism, MAP Kinase Kinase 4, Mitogen-Activated Protein Kinase Kinases metabolism, Promoter Regions, Genetic drug effects, Protein Kinase C metabolism, Rats, Steroid Hydroxylases chemistry, Steroid Hydroxylases metabolism, Transcription, Genetic, Vitamin D3 24-Hydroxylase, Calcitriol physiology, Mitogen-Activated Protein Kinases metabolism, Promoter Regions, Genetic physiology, Steroid Hydroxylases genetics, Tetradecanoylphorbol Acetate pharmacology, Transcription Factors metabolism
- Abstract
Although investigations of the transcriptional regulation of the rat cytochrome P450C24 [CYP24 (25-hydroxyvitamin D3 24-hydroxylase)] gene by 1,25D (1,25-dihydroxyvitamin D3) at either the genomic, or more recently at the non-genomic, level have provided insight into the mechanism of control of 1,25D levels, this regulation is still poorly characterized. Using HEK-293T cells (human embryonic kidney 293T cells), we reported that 1,25D induction of CYP24 requires JNK (c-Jun N-terminal kinase) but not the ERK1/2 (extracellular-signal-regulated kinase 1/2). The phenomenon of synergistic up-regulation of CYP24 expression by PMA and 1,25D is well known and was found to be protein kinase C-dependent. Whereas ERK1/2 was not activated by 1,25D alone, its activation by PMA was potentiated by 1,25D also. The importance of ERK1/2 for transcriptional synergy was demonstrated by transfection of a dominant-negative ERK1(K71R) mutant (where K71R stands for Lys71-->Arg), which resulted in a reduced level of synergy on a CYP24 promoter-luciferase construct. JNK was also shown to be required for synergy. We report, in the present study, the identification of a site located at -171/-163, about 30 bp upstream of the vitamin D response element-1 in the CYP24 proximal promoter. This sequence, 5'-TGTCGGTCA-3', is critical for 1,25D induction of CYP24 and is therefore termed the vitamin D stimulatory element. The vitamin D stimulatory element, a target for the JNK module, and an Ets-1 binding site were shown to be vital for synergy between PMA and 1,25D. This is the first report to identify the DNA binding sequences required for the synergy between PMA and 1,25D and a role for JNK on the CYP24 gene promoter.
- Published
- 2005
- Full Text
- View/download PDF
31. Identification of growth factor independent-1 (GFI1) as a repressor of 25-hydroxyvitamin D 1-alpha hydroxylase (CYP27B1) gene expression in human prostate cancer cells.
- Author
-
Dwivedi PP, Anderson PH, Omdahl JL, Grimes HL, Morris HA, and May BK
- Subjects
- 5' Flanking Region genetics, Binding Sites genetics, DNA Mutational Analysis, Enhancer Elements, Genetic, Humans, Male, Nuclear Proteins metabolism, Promoter Regions, Genetic genetics, Prostatic Neoplasms metabolism, Sequence Deletion, 25-Hydroxyvitamin D3 1-alpha-Hydroxylase genetics, DNA-Binding Proteins metabolism, Gene Expression Regulation, Neoplastic, Prostatic Neoplasms genetics, Repressor Proteins metabolism, Transcription Factors metabolism
- Abstract
The hormone 1,25-dihydroxyvitamin D (1,25D) may play a protective role in prostate cancer. 25-hydroxyvitamin D 1-alpha hydroxylase (CYP27B1) is the enzyme responsible for the regulation of cellular 1,25D levels. CYP27B1 is substantially repressed in prostate cancer cells. We have investigated the molecular basis for this inhibition. First, we identify a repressive region between -997 and -1200 in the human CYP27B1 promoter following transient transfection analysis in the prostate cancer cell lines DU145, PC3 and LNCaP. Next, we demonstrate a role for the transcription factor growth factor independent-1 (GFI1) in the repression of CYP27B1. Electrophoretic mobility assays with nuclear extracts from prostate cancer cell lines established binding of GFI1 to the sequence 5'-TGGTACAATCATAACTCACTGCAG-3' present at -997 to -1200 in the repressive region. Site directed mutagenesis of the core GFI1 binding sequence (5'-AATC-3') substantially increased while forced expression of GFI1 decreased the expression of the CYP27B1 reporter construct. Importantly, GFI1 repression is dependent on an intact GFI1 binding site in the -997 to -1200 region. GFI1 is an oncoprotein known to form a large protein complex with co-repressors that recruit histone deacetylases. We propose that the formation of such a repressive complex on the inhibitory domain of the CYP27B1 gene in prostate cancer cells could lead to silencing of either the nearby enhancer or proximal promoter domains and lead to cancer progression by reducing local production of 1,25D. These studies provide the basis for a more detailed understanding of CYP27B1 repression in prostate cancer cells and could provide a novel insight in future diagnosis and treatment.
- Published
- 2005
- Full Text
- View/download PDF
32. Modulation of CYP27B1 and CYP24 mRNA expression in bone is independent of circulating 1,25(OH)2D3 levels.
- Author
-
Anderson PH, O'Loughlin PD, May BK, and Morris HA
- Subjects
- Animals, Bone and Bones anatomy & histology, Female, Kidney enzymology, Rats, Rats, Sprague-Dawley, Receptors, Calcitriol genetics, Reverse Transcriptase Polymerase Chain Reaction, Vitamin D3 24-Hydroxylase, 25-Hydroxyvitamin D3 1-alpha-Hydroxylase genetics, Bone and Bones enzymology, Calcitriol blood, Cytochrome P-450 Enzyme System genetics, RNA, Messenger genetics, Steroid Hydroxylases genetics
- Abstract
Circulating levels of 1,25-dihydroxyvitamin D (1,25D) are determined by bioactivation catalyzed by the renal 25-hydroxyvitamin D 1alpha-hydroxylase (CYP27B1) and degradation through the action of the renal 25-hydroxyvitamin D 24-hydroxylase (CYP24). CYP27B1 and CYP24 are also present in bone cells, but little is known of their physiological role. The purpose of this study was to determine the changes that occur with aging on the expression of CYP27B1 and CYP24 mRNA in whole kidney and femora of female Sprague-Dawley rats. Real-time RT-PCR was used to measure CYP27B1, CYP24 and vitamin D receptor (VDR) mRNA levels in the kidneys and bones of animals aged between 3 weeks and 2 years. Circulating 1,25D levels decreased exponentially with age which was correlated with both reduced kidney CYP27B1 mRNA (R(2) = 0.72) and increased CYP24 mRNA levels (R(2) = 0.71). In the bone, CYP27B1 mRNA levels were maintained at their highest level throughout the ages of 3 to 15 weeks before decreasing in adult animals (P < 0.05). Bone CYP24 mRNA levels were positively correlated with bone CYP27B1 mRNA and not circulating 1,25D levels (R(2) = 0.74). Levels of bone CYP27B1 mRNA were positively correlated with distal femoral epiphyseal trabecular number (Tb.N) (R(2) = 0.74) and negatively with the trabecular thickness (Tb.Th) (R(2) = 0.56) in animals aged between 12 weeks and 2 years. These findings indicate that the regulation of CYP27B1 and CYP24 mRNA expression in the bone is unique from that in the kidney. The synthesis of 1,25D in bone tissue regulates bone CYP24 expression and is associated with bone mineralization suggesting that vitamin D metabolism has an autocrine or paracrine function.
- Published
- 2005
- Full Text
- View/download PDF
33. Response of the 5'-flanking region of the human 25-hydroxyvitamin D 1alpha-hydroxylase gene to physiological stimuli using a transgenic mouse model.
- Author
-
Hendrix I, Anderson PH, Omdahl JL, May BK, and Morris HA
- Subjects
- 25-Hydroxyvitamin D3 1-alpha-Hydroxylase biosynthesis, Age Factors, Animals, Calcium metabolism, Genes, Reporter, Immunohistochemistry, Kidney metabolism, Mice, Mice, Transgenic, Vitamin D Deficiency metabolism, 25-Hydroxyvitamin D3 1-alpha-Hydroxylase genetics, 5' Flanking Region, Gene Expression Regulation physiology, Promoter Regions, Genetic
- Abstract
The enzyme 25-hydroxyvitamin D 1alpha-hydroxylase, or CYP27B1, is the key enzyme in the two-step activation process of vitamin D to 1,25-dihydroxyvitamin D (1,25D). While a number of regulators of the renal CYP27B1 enzyme activity have been recognized for some years, their underlying molecular mechanisms remain largely unknown, and the DNA regions involved in the in vivo regulation of gene expression by these factors have not been delineated. We have generated a transgenic mouse line that expresses 1501 bp of 5' flanking region together with 44 bp of 5' untranslated region of the human CYP27B1 gene fused to the firefly luciferase reporter gene. Animals expressing the luciferase gene demonstrated that both luciferase protein and mRNA for CYP27B1 were localized to proximal convoluted tubule cells of the kidney. In 2-week-old animals, the expression of the transgene and the endogenous CYP27B1 mRNA levels in the kidney were highest and fell with increasing age. Both reporter gene expression and CYP27B1 mRNA levels were downregulated in response to increasing amounts of dietary calcium in a dose-dependent manner. Vitamin D deficiency resulted in an increase in both the reporter gene and CYP27B1 expression. Interestingly, the increase in CYP27B1 mRNA levels was substantially higher than the increase in reporter gene expression, suggesting either that there is a post-transcriptional mechanism that increases the amount of CYP27B1 mRNA or that other regulatory elements are required to maximize the effect of vitamin D deficiency. These findings demonstrate that the 1501 bp 5' flanking region of the CYP27B1 gene directs expression to the proximal convoluted tubules of the kidney and is responsible for increasing transcriptional activity when dietary calcium and vitamin D levels are depleted. It also responds in the kidney to the physiological regulators of development and ageing.
- Published
- 2005
- Full Text
- View/download PDF
34. Determinants of circulating 1,25-dihydroxyvitamin D3 levels: the role of renal synthesis and catabolism of vitamin D.
- Author
-
Anderson PH, O'Loughlin PD, May BK, and Morris HA
- Subjects
- 25-Hydroxyvitamin D3 1-alpha-Hydroxylase genetics, Animals, Calcium administration & dosage, Cytochrome P-450 Enzyme System genetics, Female, Kidney enzymology, RNA, Messenger genetics, RNA, Messenger metabolism, Rats, Rats, Sprague-Dawley, Receptors, Calcitriol genetics, Reverse Transcriptase Polymerase Chain Reaction, Steroid Hydroxylases genetics, Vitamin D3 24-Hydroxylase, Calcitriol blood, Kidney metabolism, Vitamin D metabolism
- Abstract
Details of the molecular mechanisms determining levels of the secosteroid, 1,25-dihydroxyvitamin D(3) (1,25D) remain to be elucidated. The current paradigm for the control of serum 1,25D levels is the tight regulation of renal 25-hydroxyvitamin D-1alpha-hydroxlase (CYP27B1) activity by a number of physiological factors. 1,25D production is also regulated by the cytochrome P450 enzyme, 25-hydroxyvitamin D-24-hydroxylase (CYP24), which through side chain hydroxylation reactions, inactivates 1,25D. We have recently demonstrated that renal CYP27B1 and CYP24 expression contribute equally to regulating serum 1,25D levels. We now describe the contribution of renal Vitamin D receptor (VDR) expression in determining serum 1,25D levels. Serum 1,25D levels were decreased when the dietary calcium intake was increased. We measured mRNA levels for CYP27B1, CYP24 and VDR receptor in kidney RNA extracts from animals fed diets containing different levels of calcium, ranging from 0.05 to 1%. Serum 1,25D levels were negatively correlated with renal CYP24 mRNA levels (R2 = 0.35, P < 0.01) while renal VDR is positively correlated with renal CYP24 mRNA (R2 = 0.80, P < 0.001). However, only renal VDR mRNA remained a significant determinant of renal CYP24 expression when both these variables were included in multiple linear regression analysis (multiple R2 = 0.89, P < 0.001). These findings suggest that kidney CYP24 activity acts in concert with kidney CYP27B1 to control serum 1,25D levels and that serum 1,25D stimulates renal CYP24 expression by acting through the renal VDR.
- Published
- 2004
- Full Text
- View/download PDF
35. The major splice variant of human 5-aminolevulinate synthase-2 contributes significantly to erythroid heme biosynthesis.
- Author
-
Cox TC, Sadlon TJ, Schwarz QP, Matthews CS, Wise PD, Cox LL, Bottomley SS, and May BK
- Subjects
- Alternative Splicing, Amino Acid Sequence, Animals, Base Sequence, COS Cells, Catalysis, Codon, Electrophoresis, Polyacrylamide Gel, Exons, Genetic Vectors, Green Fluorescent Proteins, Hemoglobins chemistry, Humans, Luminescent Proteins metabolism, Microscopy, Fluorescence, Mitochondria metabolism, Molecular Sequence Data, Polymerase Chain Reaction, Protein Isoforms, Protein Structure, Tertiary, RNA, Messenger metabolism, Reticulocytes metabolism, Ribonucleases metabolism, Subcellular Fractions metabolism, Succinate-CoA Ligases chemistry, Two-Hybrid System Techniques, 5-Aminolevulinate Synthetase biosynthesis, 5-Aminolevulinate Synthetase genetics, Erythrocytes metabolism, Heme biosynthesis
- Abstract
The initial step of the heme biosynthetic pathway in erythroid cells is catalyzed by an erythroid-specific isoform of 5-aminolevulinate synthase-2 (ALAS2). Previously, an alternatively spliced mRNA isoform of ALAS2 was identified although the functional significance of the encoded protein was unknown. We sought to characterize the contribution of this ALAS2 isoform to overall erythroid heme biosynthesis. Here, we report the identification of three novel ALAS2 mRNA splice isoforms in addition to the previously described isoform lacking exon 4-derived sequence. Quantitation of these mRNAs using ribonuclease protection experiments revealed that the isoform without exon 4-derived sequence represents approximately 35-45% of total ALAS2 mRNA while the newly identified transcripts together represent approximately 15%. Despite the significant amounts of these three new transcripts, their features indicate that they are unlikely to substantially contribute to overall mitochondrial ALAS2 activity. In contrast, in vitro studies show that the major splice variant (lacking exon 4-encoded sequence) produces a functional enzyme, albeit with slightly reduced activity and with affinity for the ATP-specific, beta subunit of succinyl CoA synthase, comparable to that of mature ALAS2. It was also established that the first 49 amino acids of the ALAS2 pre-protein are necessary and sufficient for translocation across the mitochondrial inner membrane and that this process is not affected by the absence of exon 4-encoded sequence. We conclude that the major splice isoform of ALAS2 is functional in vivo and could significantly contribute to erythroid heme biosynthesis and hemoglobin formation.
- Published
- 2004
- Full Text
- View/download PDF
36. Vitamin D metabolism: new concepts and clinical implications.
- Author
-
Anderson PH, May BK, and Morris HA
- Abstract
The vitamin D endocrine system plays a primary role in the maintenance of calcium homeostasis as well as exerting a wider range of biological activities including the regulation of cellular differentiation and proliferation, immunity, and reproduction. Most of these latter activities have been demonstrated using in vitro techniques. A major issue is to place such in vitro findings into their physiological context. Vitamin D exerts its genomic effects through a nuclear gene transcription factor, the vitamin D receptor (VDR), while metabolism of vitamin D both to its biologically active form, as well as to its excretory product, plays a major role in determining biological activity at the tissue level. Considerable information has become available recently concerning the metabolism of vitamin D both in the kidney and in non-renal tissues. These data confirm the endocrine action of vitamin D through renal metabolism which provides 1,25 dihydroxyvitamin D (1,25D) to the circulation. The major organ responding to the endocrine action of 1,25D is the intestine where it controls absorption of calcium and phosphate. Preliminary information regarding the contribution of tissue-specific production of 1,25D to its paracrine/autocrine activity is now becoming available. In bone cells, these data provide evidence for the modulation of cell proliferation and stimulation of bone cell maturation. The relevance of these concepts to the clinical laboratory is discussed in the context of vitamin D insufficiency and the increased risk of hip fracture amongst the elderly.
- Published
- 2003
37. Evidence that the coactivator CBP/p300 is important for phenobarbital-induced but not basal expression of the CYP2H1 gene.
- Author
-
Dogra SC, Tremethick D, and May BK
- Subjects
- Adenovirus E1A Proteins physiology, Animals, Binding Sites, Chick Embryo, Cytochrome P-450 Enzyme System genetics, Enhancer Elements, Genetic physiology, Enzyme Induction, Hepatocytes physiology, Hydroxamic Acids pharmacology, Protein Structure, Tertiary, RNA, Messenger biosynthesis, RNA, Messenger drug effects, Cytochrome P-450 Enzyme System biosynthesis, Gene Expression drug effects, Hepatocytes drug effects, Nuclear Proteins metabolism, Phenobarbital pharmacology, Trans-Activators metabolism
- Abstract
We have previously identified an upstream 556-bp enhancer domain for the chicken CYP2H1 gene that responds to phenobarbital and binds several transcription factors, including the orphan chicken xenobiotic receptor (CXR). By contrast, the promoter lacks a CXR site and is not inducible by phenobarbital. Although it has been established that CXR can interact with the coactivator SRC-1, there are no reports as to whether other coactivators may be important for phenobarbital-mediated inducibility. Our studies using the adenovirus E1A wild-type protein, which inhibits the coactivators cAMP response element binding protein (CBP) and CBP associated factor (p/CAF), provide evidence for the involvement of one or both of these coactivators at the enhancer but not at the promoter of the CYP2H1 gene. The observations that mutant E1A proteins did not affect the enhancer activity and that inhibition by wild-type E1A was reversed by CBP and p/CAF confirmed the involvement of these coactivators in the induction process. We propose that the intrinsic histone acetyl transferase activity of one or both of these coactivators participates in chromatin remodeling thereby stimulating drug induction of the promoter. This proposal was supported by experiments with the histone deacetylase inhibitor, trichostatin A, which resulted in the superinduction of the drug response but had little effect on basal expression of the CYP2H1 gene. The work provides evidence for the first time for the involvement of the coactivators CBP and p/CAF in the phenobarbital-mediated induction of the CYP2H1 gene.
- Published
- 2003
- Full Text
- View/download PDF
38. Role of MAP kinases in the 1,25-dihydroxyvitamin D3-induced transactivation of the rat cytochrome P450C24 (CYP24) promoter. Specific functions for ERK1/ERK2 and ERK5.
- Author
-
Dwivedi PP, Hii CS, Ferrante A, Tan J, Der CJ, Omdahl JL, Morris HA, and May BK
- Subjects
- Animals, COS Cells, Humans, Rats, Two-Hybrid System Techniques, Vitamin D3 24-Hydroxylase, Calcitriol pharmacology, Cytochrome P-450 Enzyme System genetics, Gene Expression Regulation, Enzymologic drug effects, Mitogen-Activated Protein Kinases metabolism, Promoter Regions, Genetic, Steroid Hydroxylases genetics, Transcriptional Activation drug effects
- Abstract
The current study investigated the action of 1,25-dihydroxyvitamin D(3) (1,25D) at the genomic and signal transduction levels to induce rat cytochrome P450C24 (CYP24) gene expression. A rat CYP24 promoter containing two vitamin D response elements and an Ets-1 binding site was used to characterize the mechanism of actions for the 1,25D secosteroid hormone. The Ets-1 binding site was determined to function cooperatively with the most proximal vitamin D response element in a hormone-dependent fashion. Evidence was obtained for distinct roles of ERK1/ERK2 and ERK5 in the 1,25D-inductive actions. Specifically, 1,25D stimulated the activities of ERK1/ERK2 and ERK5 in a Ras-dependent manner. Promoter induction was inhibited by mitogen-activated protein (MAP) kinase inhibitors (PD98059 and U0126) and a dominant-negative Ras mutant (Ras17N). Induction of CYP24 by 1,25D was also inhibited by overexpression of dominant-negative mutants of ERK1 and MEK5 (ERK1K71R and MEK5(A)). The p38 and JNK MAP kinases were not required for the action of 1,25D. 9-cis retinoid X receptor alpha (RXR alpha) interacted with ERK2 but not ERK5 in intact cells, whereas Ets-1 interacted preferentially with ERK5. Increased phosphorylation of RXR alpha and Ets-1 was detected in response to 1,25D. Activated ERK2 and ERK5 specifically phosphorylated RXR alpha and Ets-1, respectively. Mutagenesis of Ets-1 (T38A) reduced CYP24 promoter activity to levels observed with the dominant-negative MEK5(A) and inhibited ERK5-directed phosphorylation. Mutated RXR alpha (S260A) inhibited 1,25D-induced CYP24 promoter activity and abolished phosphorylation by activated ERK2. The 1,25D-inductive action through ERK5 involved Ets-1 phosphorylation at threonine 38, whereas hormone stimulation of ERK1/ERK2 required RXR alpha phosphorylation on serine 260. The ERK1/ERK2 and ERK5 modules provide a novel mechanism for linking the rapid signal transduction and slower transcription actions of 1,25D to induce CYP24 gene expression.
- Published
- 2002
- Full Text
- View/download PDF
39. Basal and parathyroid hormone induced expression of the human 25-hydroxyvitamin D 1alpha-hydroxylase gene promoter in kidney AOK-B50 cells: role of Sp1, Ets and CCAAT box protein binding sites.
- Author
-
Gao XH, Dwivedi PP, Choe S, Alba F, Morris HA, Omdahl JL, and May BK
- Subjects
- 5' Flanking Region, Binding Sites, Cell Line, Humans, Kidney cytology, Proto-Oncogene Proteins c-ets, 25-Hydroxyvitamin D3 1-alpha-Hydroxylase genetics, Gene Expression, Parathyroid Hormone pharmacology, Peptide Fragments pharmacology, Promoter Regions, Genetic, Proto-Oncogene Proteins metabolism, Sp1 Transcription Factor metabolism, Transcription Factors metabolism
- Abstract
The regulation of the gene for renal 25-hydroxyvitamin D 1alpha- hydroxylase (1alpha(OH)ase; CYP27B1) by parathyroid hormone (PTH) under hypocalcemic conditions is fundamentally important for the maintenance of calcium and phosphate homeostasis. The molecular mechanism that underlies this hormonal response is of current interest and has been investigated in the present study by transfection analysis of the human 1alpha(OH)ase promoter in kidney AOK-B50 cells. We have shown that the first 305 bp of promoter can be induced by hormone in transient transfection assays and also within a chromatin environment when stably integrated. Mutagenesis of possible transcription factor binding sites within this promoter length has shown that three sites clustered within the region from -66 to -135 contribute to basal expression. A likely Sp1 and a CCAAT box site are particularly important for basal expression although these sites are not likely to functionally cooperate in a major way. Mutagenesis of the CCAAT box site consistently reduced PTH induction although mutagenesis of the Sp1, Ets and other possible binding sites in the 305 bp of promoter has no significant effect on the level of PTH induction. Other experiments showed that PTH induction but not basal expression was sensitive to the protein kinase inhibitor H89. We have therefore identified for the first time the sites in the 1alpha(OH)ase promoter responsible for basal expression and provide evidence for the role of a CCAAT box binding protein in a PTH mechanism of induction that involves an H89 sensitive step.
- Published
- 2002
- Full Text
- View/download PDF
40. Hydroxylase enzymes of the vitamin D pathway: expression, function, and regulation.
- Author
-
Omdahl JL, Morris HA, and May BK
- Subjects
- Homeostasis, Humans, Secosteroids metabolism, Steroid Hydroxylases metabolism, Steroid Hydroxylases physiology, Transcription, Genetic, Vitamin D physiology, Cytochrome P-450 Enzyme System metabolism, Gene Expression Regulation physiology, Mixed Function Oxygenases metabolism, Vitamin D analogs & derivatives, Vitamin D metabolism
- Abstract
Vitamin D is a secosteroid that is metabolically activated and degraded through the actions of three cytochrome P450 hydroxylase enzymes. Bioactivation occurs through the sequential actions of cytochromes P450C25 and P450C1, resulting in synthesis of the pleiotropic hormone 1,25-dihydroxyvitamin D (1,25VD), which regulates over 60 genes whose actions include those associated with calcium homeostasis and immune responses as well as cellular growth, differentiation, and apoptosis. Inactivation of 1,25VD occurs by C23/C24 oxidation pathways that are catalyzed by the multifunctional cytochrome P450C24 enzyme. Both P450C1 and P450C24 are highly regulated enzymes whose differential expression is controlled in response to numerous cellular modulatory agents such as parathyroid hormone (PTH), calcitonin, interferon gamma, calcium, phosphorus, and pituitary hormones as well as the secosteroid hormone 1,25VD. Most thoroughly studied at the molecular level are the actions of PTH to upregulate P450C1 gene expression and 1,25VD to induce the expression of P450C24. The regulatory action of PTH is mediated through the protein kinase A pathway and involves the phosphorylation of transcription factors that function at the proximal promoter of the P450C1 gene. The upregulation of P450C24 by 1,25VD has both a rapid nongenomic and a slower genomic component that are functionally linked. The rapid response involves protein kinase C and mitogen-activated protein kinase (MAPK) pathways that direct the phosphorylation of nuclear transcription factors. The slower genomic actions are linked to the binding of 1,25VD to the vitamin D receptor (VDR) and the interaction of the VDR-1,25VD complex with its heterodimer partner retinoid-X-receptor and associated coactivators. The regulatory complex is assembled on vitamin D response elements in the proximal promoter of the P450C24 gene and functions to increase the transcription rate.
- Published
- 2002
- Full Text
- View/download PDF
41. A duplicated HNF-3 binding site in the CYP2H2 promoter underlies the weak phenobarbital induction response.
- Author
-
Davidson BP, Dogra SC, and May BK
- Subjects
- Animals, Base Sequence, Cell Nucleus genetics, Cell Nucleus metabolism, Cells, Cultured, Chick Embryo, Cloning, Molecular, DNA Footprinting, Electrophoretic Mobility Shift Assay, Hepatocytes drug effects, Hepatocytes metabolism, Molecular Sequence Data, Mutagenesis, Site-Directed, Sequence Deletion genetics, Transfection, Cytochrome P-450 Enzyme System genetics, Gene Expression Regulation drug effects, Phenobarbital pharmacology, Promoter Regions, Genetic genetics, Repetitive Sequences, Nucleic Acid genetics, Response Elements genetics, Transcription Factors metabolism
- Abstract
We are investigating induction of chicken cytochrome P450 genes by the sedative phenobarbital in chick embryo hepatocytes. The steady-state level of induced mRNA for the gene CYP2H1 is about 10-fold higher than that of a second gene, CYP2H2. Here, we show that a difference in drug-responsive enhancer activity does not underlie the differential response of these genes to phenobarbital since upstream enhancer regions are identical in these genes. The first 198 bp of CYP2H2 promoter sequence is identical to the CYP2H1 gene promoter, except that the functional HNF-3 binding site in the CYP2H1 promoter is replaced with a duplicated HNF-3 sequence in the CYP2H2 promoter. Transient expression analysis established that the promoter activity of the CYP2H2 gene was about ninefold lower than the CYP2H1 gene. Mutagenesis of either of the partially overlapping HNF-3 sites in the CYP2H2 gene substantially induced drug induction. Gel-shift analysis established that each of these HNF-3 sites bound HNF-3, most likely HNF-3beta. In-vitro footprint analysis demonstrated that all the identified sites in the CYP2H2 promoter bound protein except the duplicated HNF-3 region. However, protein binding was observed by in-vitro footprint analysis if either of the HNF-3 sites was mutated in the CYP2H2 promoter. Hence, duplication of the HNF-3 site in the CYP2H2 promoter does not allow binding of HNF-3 in the promoter context and may be predominantly, if not exclusively, responsible for the poor response of the CYP2H2 gene to phenobarbital.
- Published
- 2001
- Full Text
- View/download PDF
42. The antiglucocorticoid RU486 inhibits phenobarbital induction of the chicken CYP2H1 gene in primary hepatocytes.
- Author
-
Davidson BP, Dogra SC, and May BK
- Subjects
- Animals, Cells, Cultured, Chick Embryo, Dexamethasone pharmacology, Drug Interactions, Enhancer Elements, Genetic drug effects, Excitatory Amino Acid Antagonists pharmacology, Glucocorticoids pharmacology, Hepatocytes enzymology, Medroxyprogesterone Acetate pharmacology, Pregnane X Receptor, Progesterone Congeners pharmacology, RNA, Messenger drug effects, RNA, Messenger metabolism, Receptors, Cytoplasmic and Nuclear drug effects, Receptors, Cytoplasmic and Nuclear metabolism, Receptors, Steroid drug effects, Receptors, Steroid metabolism, Recombinant Fusion Proteins metabolism, Transcription Factors metabolism, Cytochrome P-450 Enzyme System metabolism, Hepatocytes drug effects, Hormone Antagonists pharmacology, Mifepristone pharmacology, Phenobarbital pharmacology
- Abstract
The cytochrome P450 gene CYP2H1 is highly induced by phenobarbital in chick embryo hepatocytes. Recent studies have established that the orphan nuclear receptor CAR plays a critical role in the induction mechanism. Here, we show that a high concentration of the potent glucocorticoid and progesterone receptor antagonist RU486 almost completely blocks phenobarbital-induced accumulation of CYP2H1 mRNA in hepatocytes yet has no effect on basal expression. In marked contrast, CYP2H1 mRNA induced by the phenobarbital-type inducers glutethimide and 2-allylisopropylacetamide is not affected by RU486. RU486 inhibition is not mediated through the glucocorticoid or progesterone receptors. Transient transfection studies showed that RU486 does not repress through activation of the orphan receptor PXR and subsequent competition with CAR for binding to the upstream drug-responsive 556-base-pair enhancer. Additionally, none of the known functional transcription factor binding sites found in the enhancer region was a target of RU486 inhibition. Using an artificial construct containing multiple CAR binding sites, we also established that RU486 has no direct effect on the activity of exogenously expressed CAR. There is no evidence that phenobarbital binds to CAR; we propose that RU486 inhibits phenobarbital induction, either by interfering with a phenobarbital-dependent mechanism responsible for nuclear import of CAR or with the metabolism of phenobarbital to the true inducer. Whether a novel nuclear receptor that binds RU486 at high concentrations plays a role in the inhibitory action of RU486 is an interesting possibility.
- Published
- 2001
- Full Text
- View/download PDF
43. Overview of regulatory cytochrome P450 enzymes of the vitamin D pathway.
- Author
-
Omdahl JL, Bobrovnikova EA, Choe S, Dwivedi PP, and May BK
- Subjects
- Amino Acid Sequence, Animals, Calcitriol biosynthesis, Cytochrome P-450 Enzyme System metabolism, Gene Expression Regulation, Humans, Molecular Sequence Data, Sequence Alignment, Steroid Hydroxylases metabolism, Steroid Hydroxylases physiology, Vitamin D physiology, Steroid Hydroxylases genetics, Vitamin D metabolism
- Abstract
Cytochromes P450c1 and P450c24 are regulated hydroxylase enzymes that direct the bioactivation and metabolic degradation of vitamin D. The bioactivation pathway is regulated by cytochrome P450c1 through its synthesis of 1alpha,25(OH)(2)D(3), the hormonally active form of the vitamin. Expression of the P450c1 gene is regulated at the transcription level. Promoter regions within the P450c1 gene have been identified that respond to cAMP and 1alpha,25(OH)(2)D(3) during the respective up- and down-regulation of P450c1 gene expression. The diametric action of 1alpha,25(OH)(2)D(3) to up-regulate P450c24 gene expression is discussed in the context of two vitamin D response elements (VDREs) that are linked functionally to an adjoining Ets-binding site. It is apparent from sequence-derived data that the P450c1 and P450c24 enzymes share only 10-25% sequence identity, yet they display functionally similar domains that are conserved across the family of cytochrome P450 enzymes. Expression of E. coli recombinant P450c1 and P450c24 enzymes, and the substrate-binding parameters for P450c24 are discussed. Finally, the natural point mutations in human P540c1 from patients with pseudovitamin D-deficiency rickets (PDDR) are discussed in the context of the enzyme's structure and function.
- Published
- 2001
- Full Text
- View/download PDF
44. Osteoblast gene expression in rat long bones: effects of ovariectomy and dihydrotestosterone on mRNA levels.
- Author
-
Davey RA, Hahn CN, May BK, and Morris HA
- Subjects
- Animals, Dihydrotestosterone administration & dosage, Female, Femur drug effects, Gene Expression drug effects, Humans, Osteoblasts cytology, Osteoblasts drug effects, Osteopontin, Ovariectomy adverse effects, RNA, Messenger, Rats, Rats, Sprague-Dawley, Tibia drug effects, Alkaline Phosphatase genetics, Collagen genetics, Dihydrotestosterone metabolism, Estrogens metabolism, Femur metabolism, Osteoblasts metabolism, Osteocalcin genetics, Sialoglycoproteins genetics, Tibia metabolism
- Abstract
The steroid sex hormones exert major effects on bone formation although the molecular events associated with their activity remain unclear. We have investigated the effects of ovariectomy and dihydrotestosterone (DHT) administration to both sham-operated and ovariectomized (ovx) rats on the bone mRNA levels of osteoblast genes. Rats were randomly allocated to either sham or ovariectomy operations and were administered either vehicle or 40 mg/ kg body weight DHT by silastic tube implants at the time of operation for 8 weeks, at which time they were killed and total RNA was extracted from the long bones. Northern blot analysis indicated that the mRNA levels of the bone cell genes alpha1(I) collagen, alkaline phosphatase, osteocalcin, and osteopontin were markedly increased in ovx rats between 6- and 30-fold. DHT administration to ovary-intact, estrogen-sufficient rats increased the mRNA levels of alpha1(I) collagen, alkaline phosphatase, osteopontin, and osteocalcin between 3- and 9-fold. In contrast, DHT did not alter levels of these mRNA species in ovx rats. The data demonstrate that estrogen deficiency increased mRNA levels of genes expressed during osteoblast development and suggest an interplay between estrogen and androgen action in regulating the expression of a number of bone cell genes.
- Published
- 2000
- Full Text
- View/download PDF
45. Regulation of rat cytochrome P450C24 (CYP24) gene expression. Evidence for functional cooperation of Ras-activated Ets transcription factors with the vitamin D receptor in 1,25-dihydroxyvitamin D(3)-mediated induction.
- Author
-
Dwivedi PP, Omdahl JL, Kola I, Hume DA, and May BK
- Subjects
- Animals, Binding Sites, Cytochrome P-450 Enzyme System biosynthesis, Dimerization, Gene Expression Regulation, Enzymologic, Nuclear Proteins metabolism, Promoter Regions, Genetic, Protein Binding, Proto-Oncogene Protein c-ets-1, Proto-Oncogene Proteins c-ets, Proto-Oncogene Proteins c-raf metabolism, Rats, Receptors, Retinoic Acid metabolism, Retinoid X Receptors, Steroid Hydroxylases biosynthesis, Transcription Factor AP-1 metabolism, Vitamin D3 24-Hydroxylase, Calcitriol pharmacology, Cytochrome P-450 Enzyme System genetics, Proto-Oncogene Proteins metabolism, Receptors, Calcitriol metabolism, Response Elements, Steroid Hydroxylases genetics, Transcription Factors metabolism, Transcriptional Activation, ras Proteins metabolism
- Abstract
Transcription of the rat CYP24 gene is induced by 1, 25-dihydroxyvitamin D(3) (1,25-(OH)(2)D(3)) through two vitamin D response elements (VDREs). A functional Ras-dependent Ets-binding site (EBS) was located downstream from the proximal VDRE and was critical to 1,25(OH)(2)D(3)-mediated induction. Cotransfection of Ets-1 and Ets-2 stimulated induction, which was lost when the EBS was mutated. Multiple nuclear-protein complexes from COS-1 cells bound to the EBS in which three complexes were immunologically related to Ets-1. Transcriptional synergy was observed between the proximal VDRE and adjacent EBS as was the attendant formation of a ternary complex between vitamin D receptor- retinoid X receptor (VDR. RXR) and Ets-1. In the absence of 1,25-(OH)(2)D(3) or in the presence of an inactive proximal VDRE, the EBS failed to respond to exogenous Ets-1. However, Ets-1 increased basal expression when cotransfected with a mutant VDR. The inductive action of 1, 25-(OH)(2)D(3) was substantially increased by Ras, which was ablated by mutagenesis of the EBS or by expression of a mutated Ets-1 protein (T38A). EBS contribution to hormone induction was prevented by manumycin A, an inhibitor of Ras farnesylation. A fundamental role was established for transcriptional cooperation between Ras-activated Ets proteins and the VDR.RXR complex in mediating 1, 25-(OH)(2)D(3) action on the CYP24 promoter.
- Published
- 2000
- Full Text
- View/download PDF
46. Regulation of erythroid 5-aminolevulinate synthase expression during erythropoiesis.
- Author
-
Sadlon TJ, Dell'Oso T, Surinya KH, and May BK
- Subjects
- Anemia, Sideroblastic enzymology, Animals, Cell Differentiation, Enhancer Elements, Genetic, Erythroid Precursor Cells enzymology, Heme biosynthesis, Heme physiology, Humans, Introns, Iron metabolism, Protein Biosynthesis, Transcription Factors metabolism, 5-Aminolevulinate Synthetase genetics, Erythropoiesis physiology, Gene Expression Regulation, Enzymologic
- Abstract
Erythroid tissue is the major site of heme production in the body. The synthesis of heme and globin chains is coordinated at both the transcriptional and post-transcriptional levels to ensure that virtually no free heme or globin protein accumulates. The key rate-controlling enzyme of the heme biosynthetic pathway is 5-aminolevulinate synthase (ALAS) and an erythroid-specific isoform (ALAS2) is up-regulated during erythropoiesis. Differentiation of embryonic stem cells with a disrupted ALAS2 gene has established that expression of this gene is critical for erythropoiesis and cannot be compensated by expression of the ubiquitous isoform of the enzyme (ALAS1). Interestingly, heme appears to be important for expression of globin and other late erythroid genes and for erythroid cell differentiation although the mechanism of this effect is not clear. Transcriptional control elements that regulate the human gene for ALAS2 have been identified both in the promoter and in intronic enhancer regions. Subsequent translation of the ALAS2 mRNA is dependent on an adequate iron supply. The mechanism by which transcription of the gene for ALAS2 is increased by erythropoietin late in erythropoiesis remains an interesting issue. Erythropoietin action may result in altered levels of critical erythroid transcription factors or modulate the phosphorylation/acetylation status of these factors. Defects in the coding region of the gene for ALAS2 underlie the disease state X-linked sideroblastic anemia. In this review, we focus on the regulation and function of erythroid-specific 5-aminolevulinate synthase during erythropoiesis and its role in the X-linked sideroblastic anemia.
- Published
- 1999
- Full Text
- View/download PDF
47. Expression of 25(OH)D3 24-hydroxylase in distal nephron: coordinate regulation by 1,25(OH)2D3 and cAMP or PTH.
- Author
-
Yang W, Friedman PA, Kumar R, Omdahl JL, May BK, Siu-Caldera ML, Reddy GS, and Christakos S
- Subjects
- 8-Bromo Cyclic Adenosine Monophosphate pharmacology, Animals, Base Sequence, Cells, Cultured, Cyclic AMP pharmacology, Enzyme Induction, Gene Expression Regulation, Enzymologic drug effects, Kidney Tubules, Distal enzymology, Mice, Molecular Sequence Data, RNA, Messenger genetics, Rats, Recombinant Fusion Proteins biosynthesis, Regulatory Sequences, Nucleic Acid, Steroid Hydroxylases biosynthesis, Teriparatide pharmacology, Tetradecanoylphorbol Acetate pharmacology, Transcription, Genetic drug effects, Transfection, Vitamin D3 24-Hydroxylase, Calcitriol pharmacology, Cyclic AMP physiology, Cytochrome P-450 Enzyme System, Gene Expression Regulation, Enzymologic physiology, Kidney Tubules enzymology, Nephrons enzymology, Parathyroid Hormone physiology, Steroid Hydroxylases genetics
- Abstract
Previous studies using microdissected nephron segments reported that the exclusive site of renal 25-hydroxyvitamin D3-24-hydroxylase (24OHase) activity is the renal proximal convoluted tubule (PCT). We now report the presence of 24OHase mRNA, protein, and activity in cells that are devoid of markers of proximal tubules but express characteristics highly specific for the distal tubule. 24OHase mRNA was undetectable in vehicle-treated mouse distal convoluted tubule (DCT) cells but was markedly induced when DCT cells were treated with 1,25 dihydroxyvitamin D3 [1,25(OH)2D3]. 24OHase protein and activity were also identified in DCT cells by Western blot analysis and HPLC, respectively. 8-Bromo-cAMP (1 mM) or parathyroid hormone [PTH-(1-34); 10 nM] was found to potentiate the effect of 1, 25(OH)2D3 on 24OHase mRNA. The stimulatory effect of cAMP or PTH on 24OHase expression in DCT cells suggests differential regulation of 24OHase expression in the PCT and DCT. In the presence of cAMP and 1, 25(OH)2D3, a four- to sixfold induction in vitamin D receptor (VDR) mRNA was observed. VDR protein, as determined by Western blot analysis, was also enhanced in the presence of cAMP. Transient transfection analysis in DCT cells with rat 24OHase promoter deletion constructs demonstrated that cAMP enhanced 1, 25(OH)2D3-induced 24OHase transcription but this enhancement was not mediated by cAMP response elements (CREs) in the 24OHase promoter. We conclude that 1) although the PCT is the major site of localization of 24OHase, 24OHase mRNA and activity can also be localized in the distal nephron; 2) both PTH and cAMP modulate the induction of 24OHase expression by 1,25(OH)2D3 in DCT cells in a manner different from that reported in the PCT; and 3) in DCT cells, upregulation of VDR levels by cAMP, and not an effect on CREs in the 24OHase promoter, is one mechanism involved in the cAMP-mediated modulation of 24OHase transcription.
- Published
- 1999
- Full Text
- View/download PDF
48. Analysis of a phenobarbital-responsive enhancer sequence located in the 5' flanking region of the chicken CYP2H1 gene: identification and characterization of functional protein-binding sites.
- Author
-
Dogra SC, Davidson BP, and May BK
- Subjects
- Animals, Binding Sites, Chick Embryo, Deoxyribonuclease I pharmacology, Mutagenesis, Site-Directed, Cytochrome P-450 Enzyme System genetics, Enhancer Elements, Genetic, Phenobarbital pharmacology, Transcription Factors metabolism
- Abstract
We previously identified in the chicken CYP2H1 gene an upstream enhancer domain (-5900/-1100) that responds to phenobarbital. Deletion and restriction enzyme analyses of this domain have now identified two separate enhancer regions that respond to phenobarbital (from -5900 to -4550 and from -1956 to -1400). We have focused here on the latter and in particular a resident 240-base pair (bp) restriction enzyme fragment that retains drug responsiveness. Using deletion analysis and in vitro DNase I footprinting, transcription factor binding sites have been located in the 240-bp fragment. The sites identified are an E-box-like element, a consensus hepatocyte nuclear factor 1 site, a CCAAT box motif, and a novel site. Mutagenesis demonstrated that each site contributed to enhancer activity, although there was a weaker contribution from the CCAAT box, and that no individual site was critical for responsiveness. In keeping with the tissue-restricted expression of the CYP2H1 gene, gel shift experiments established that the proteins binding to these enhancer sites are enriched in chicken liver, kidney, and small intestine. In vitro footprint experiments showed a stronger protection with liver nuclear extracts from drug-treated chickens compared with control extracts on the E-box-like element, the CCAAT box motif, and the novel binding site; however, the basis for this apparent increase in binding remains to be determined. The proteins binding to the 240-bp fragment are different from those recently reported to be required for the activity of the phenobarbital responsive enhancer domains of rodent CYP2 genes.
- Published
- 1999
- Full Text
- View/download PDF
49. Identification and characterization of a conserved erythroid-specific enhancer located in intron 8 of the human 5-aminolevulinate synthase 2 gene.
- Author
-
Surinya KH, Cox TC, and May BK
- Subjects
- 5-Aminolevulinate Synthetase metabolism, Animals, Base Sequence, DNA, DNA Footprinting, Dogs, Genes, Reporter, Humans, Mice, Molecular Sequence Data, Mutagenesis, Site-Directed, Phylogeny, Promoter Regions, Genetic, Protein Binding, Regulatory Sequences, Nucleic Acid, Sequence Homology, Amino Acid, Transcription Factors metabolism, 5-Aminolevulinate Synthetase genetics, Conserved Sequence, Enhancer Elements, Genetic, Erythrocytes enzymology, Introns
- Abstract
Thirty five kilobases of sequence encompassing the human erythroid 5-aminolevulinate synthase (ALAS2) gene have been determined. Analysis revealed a very low GC content, few repetitive elements, and evidence for the insertion of a reverse-transcribed mRNA sequence and a neighboring gene. We have investigated whether introns 1, 3, and 8, which correspond to DNase I-hypersensitivity sites in the structurally related mouse ALAS2 gene, affect expression of the human ALAS2 promoter in transient expression assays. Whereas intron 3 was marginally inhibitory, introns 1 and 8 of the human gene stimulated promoter activity. Intron 8 harbored a strong erythroid-specific enhancer activity which was orientation-dependent. Deletion analysis of this region localized enhancer activity to a fragment of 239 base pairs. Transcription factor binding sites clustered within this region include GATA motifs and CACCC boxes, critical regulatory sequences of many erythroid cell-expressed genes. These sites were also identified in the corresponding intron of both the murine and canine ALAS2 genes. Mutagenesis of these conserved sites in the human intron 8 sequence and transient expression analysis in erythroid cells established the functional importance of one GATA motif and two CACCC boxes. The GATA motif bound GATA-1 in vitro. The two functional CACCC boxes each bound Sp1 or a related protein in vitro, but binding of the erythroid Krüppel-like factor and the basic Krüppel-like factor could not be detected. The intron 8 enhancer region was not activated by GATA-1 together with Sp1 in transactivation experiments in COS-1 cells indicating the involvement of a related Sp1 protein or of another unidentified erythroid factor. Overall, these results demonstrate that a GATA-1-binding site and CACCC boxes located within the human ALAS2 intron 8 are critical for the erythroid-specific enhancer activity in transfected erythroid cells, and due to the conserved nature of these binding sites across species, it seems likely that these sites play a functional role in the tissue-restricted expression of the gene in vivo.
- Published
- 1998
- Full Text
- View/download PDF
50. Transcriptional activation of cytochrome P450 genes by different classes of chemical inducers.
- Author
-
Dogra SC, Whitelaw ML, and May BK
- Subjects
- Animals, Enzyme Induction drug effects, Enzyme Induction genetics, Humans, Xenobiotics classification, Cytochrome P-450 Enzyme System biosynthesis, Cytochrome P-450 Enzyme System genetics, Gene Expression Regulation, Enzymologic drug effects, Transcriptional Activation drug effects, Transcriptional Activation genetics, Xenobiotics pharmacology
- Abstract
1. We review here the molecular mechanisms underlying the xenobiotic induction of genes encoding cytochrome P450 (CYP) enzymes in the liver and other tissues. We will focus on four major families of CYP genes. 2. Members of the CYP1 gene family are induced by polycyclic aromatic hydrocarbons and this process is mediated by the basic helix-loop-helix proteins: the Ah receptor and its heterodimeric partner Arnt. Considerable progress has been made in elucidating the molecular details of this induction process. 3. CYP4 genes are activated by peroxisomal proliferators, a group of structurally diverse chemicals that also induce peroxisome proliferation. The transcriptional response is dependent on the peroxisome proliferator-activated receptor and its partner RXR, both members of the nuclear receptor superfamily; their role in the induction process has been well characterized at the molecular level. 4. In contrast, the mechanism of gene induction of CYP2 genes by phenobarbital and other structurally diverse inducers is not well understood and a specific phenobarbital-responsive receptor has not been identified. 5. Induction of the CYP3 gene family by the glucocorticoid dexamethasone appears to involve the glucocorticoid receptor, but this receptor is not apparently required for induction by metapyrone and a complete molecular understanding of the induction processes is lacking at present.
- Published
- 1998
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.